Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer - Concepedia

Concepedia

Publication | Open Access

Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer

DOI Full Paper Access

32

Citations

50

References

2014

Year

Chelsea Bolyard, Ji Young Yoo, Pin-Yi Wang, Uksha Saini, Kellie S. Rath, Timothy P. Cripe, Jianying Zhang, Karuppaiyah Selvendiran, Balveen Kaur

Clinical Cancer Research

Abstract

This study indicates significant antitumor efficacy of 34.5ENVE alone, and in combination with doxorubicin against disseminated peritoneal ovarian cancer.

References

	Year	Citations

Page 1